Fieldstone Bio targets disruption without interruption


Richard Roberts

Top image :
Fieldstone Bio chief science officer and co-founder, Brandon
‘Our technology reads the target elements at the pace of drilling rather than the pace of the lab’

Brandon Fields, chief science officer and co-founder of US-based Fieldstone Bio, thinks density of sampling and not just advanced analytics will deliver vital gains in mining orebody knowledge over the next decade and he’s confident microbial biosensors have a key role to play in the economics of that future.

“We give the geologist a low-cost, high-density read within a day of the sample coming out of the ground that facilitates real-time decision-making,” Fields told InvestMETS.com after the Boston-headquartered start-up was chosen to be part of a tech accelerator program run by Founders Factory and mining major Rio Tinto.

“Our technology directly reads the target elements in a sample at the pace of drilling rather than the pace of the lab.

This content is available to Paid Subscribers only. If you are already a subscriber, login using the panel below or visit our Subscribe page to view subscription packages and/or Subscribe now.

Not registered? Register Now